Characterizing the belinostat response in patients with relapsed or refractory angioimmunoblastic T-cell lymphoma Research Letter
| Authors: | Sawas, A.; Ma, H.; Shustov, A.; Hsu, P.; Bhat, G.; Acosta, M.; Horwitz, S.; O’Connor, O. A. |
| Title: | Characterizing the belinostat response in patients with relapsed or refractory angioimmunoblastic T-cell lymphoma |
| Keywords: | cancer chemotherapy; cancer survival; clinical article; treatment response; aged; survival analysis; overall survival; prednisone; allogeneic stem cell transplantation; drug tolerability; fatigue; neutropenia; doxorubicin; cancer combination chemotherapy; diarrhea; drug dose reduction; drug efficacy; drug safety; drug withdrawal; monotherapy; systemic therapy; cancer patient; letter; progression free survival; antineoplastic metal complex; multiple cycle treatment; anemia; leukopenia; nausea; thrombocytopenia; vomiting; cohort analysis; cyclophosphamide; vincristine; autologous stem cell transplantation; asthenia; fever; pruritus; hypotension; pancytopenia; romidepsin; pralatrexate; belinostat; phase 2 clinical trial (topic); septic shock; multicenter study (topic); angioimmunoblastic t cell lymphoma; cancer prognosis; intention to treat analysis; human; male; female; priority journal; patient history of chemotherapy; treatment response time; relapsed or refractory angioimmunoblastic t cell lymphoma |
| Journal Title: | Leukemia and Lymphoma |
| Volume: | 61 |
| Issue: | 8 |
| ISSN: | 1042-8194 |
| Publisher: | Taylor & Francis Group |
| Date Published: | 2020-08-01 |
| Start Page: | 2003 |
| End Page: | 2007 |
| Language: | English |
| DOI: | 10.1080/10428194.2020.1753044 |
| PUBMED: | 32336176 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Letter -- Export Date: 1 September 2020 -- Source: Scopus |
